Alendronate/Vitamin D for attenuating bone mineral density loss during antiretroviral initiation: a pilot randomized controlled trial-Reference-Cited by-同舟云学术

Alendronate/Vitamin D for attenuating bone mineral density loss during antiretroviral initiation: a pilot randomized controlled trial

Author:

Tan Darrell H. S.¹²³⁴⁵,Lee Terry⁶,Raboud Janet⁵⁷,Qamar Attia²,Cheung Angela M.³⁵⁷⁸,Walmsley Sharon³⁴⁵

Affiliation:

1. Division of Infectious Diseases, St. Michael’s Hospital, Toronto, Ontario, Canada;

2. MAP Centre for Urban Health Solutions, St. Michael’s Hospital, Toronto, Ontario, Canada;

3. Department of Medicine, University of Toronto, Toronto, Ontario, Canada;

4. Division of Infectious Diseases, Toronto General Hospital, Toronto, Ontario, Canada;

5. Toronto General Hospital Research Institute, Toronto, Ontario, Canada;

6. CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada;

7. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada;

8. Centre for Excellence in Skeletal Health Assessment, Toronto General Hospital, Toronto, Ontario, Canada

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

Reference43 articles.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献